Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma

Background: The role of body mass index (BMI) in the treatment outcomes of lymphoma patients is controversial. While investigating the efficacy of ABVD-like regimen in Hodgkin lymphoma (HL) patients, we observed that obese patients had poor responses. To better understand this clinical phenomenon, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Min, Ding, Yiduo, Zhang, Haizhou, Guo, Wei, Li, Yun, Jin, Zhengming, Qu, Changju, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482088/
https://www.ncbi.nlm.nih.gov/pubmed/37680722
http://dx.doi.org/10.3389/fphar.2023.1195907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482088/
https://www.ncbi.nlm.nih.gov/pubmed/37680722
http://dx.doi.org/10.3389/fphar.2023.1195907

Ejemplares similares